Cns Pharmaceuticals Inc (CNSP)’s stock is trading at $0.09 at the moment marking a fall of -3.05% from the last session close. As of this writing, shares are priced at -99.61% less than their 52-week high of $23.90, and 10.42% over their 52-week low of $0.08. Based on the past 30-day period, the stock price is -42.72% below the high and +11.62% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CNSP’s SMA-200 is $2.2177.
CNSP’s price to book ratio for the most recent quarter was 0.92, resulting in an 0.76 price to cash per share for the period.
How does Cns Pharmaceuticals Inc (CNSP) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Cns Pharmaceuticals Inc (NASDAQ: CNSP) Ownership Details
I will give a breakdown of the key shareholders in Cns Pharmaceuticals Inc (CNSP). Recent figures show that the company’s insiders hold 1.04% of shares. A total of 12 institutional investors hold shares in the company, making 0.79% of its stock and 0.80% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is Geode Capital Management, LLC holding total of 203.18 shares that make 0.27% of the company’s total number of shares and are currently priced at 18773.0.
The securities firm UBS Group AG holds 181.87 shares of CNSP, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.24%, and the holding percentage of shares is valued at 16804.0.
An overview of Cns Pharmaceuticals Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Cns Pharmaceuticals Inc (CNSP) traded 31,551,711 shares per day, with a moving average of $0.1066 and price change of -0.0237. With the moving average of $0.1100 and a price change of -0.0268, about 16,681,270 shares changed hands on average over the past 50 days. Finally, CNSP’s 100-day average volume is 17,111,232 shares, alongside a moving average of $0.1203 and a price change of -0.0488.
